Interestingly, a recent report demonstrates that a gene therapy approach targeting CRTC1 to enhance expression of specific synaptic genes prevents memory impairments in an AD mouse model (Parra-Damas et al., 2014). This evidence concerns the gene CRTC1 and Alzheimer disease.